COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH:

Key Record Dates Identifier: NCT02267967
Brief Title: Phase Ib/II Study of Sulfatinib in Treating Advanced Neuroendocrine Tumors

First Submitted : October 10, 2014
First Submitted that Met QC Criteria : October 15, 2014
First Posted : October 20, 2014 (Estimate)

Last Update Submitted that Met QC Criteria : November 9, 2018
Last Update Posted : November 13, 2018